Home › OncoMed Pharmaceuticals CEO Testifies on Behalf of BIO at Congressional Hearing on FDA Drug ...
 

Keywords :   


OncoMed Pharmaceuticals CEO Testifies on Behalf of BIO at Congressional Hearing on FDA Drug ...

2013-12-12 06:00:00| Industrial Newsroom - All News for Today

House Committee on Oversight & Government Reform, Subcommittee on Energy Policy, Health Care & Entitlements held a hearing entitled, "FDA Check-Up: Drug Development and Manufacturing Challenges." Paul Hastings, Chairman and CEO of OncoMed Pharmaceuticals and Chairman of BIO’s Emerging Companies Section Governing Board, presented testimony emphasizing the positive indicators that demonstrate the biopharma industry is rebounding, but significant financial and regulatory challenges ...This story is related to the following:Green & CleanSearch for suppliers of:

Tags: on drug behalf bio

Category:Industrial Goods and Services

Latest from this category

All news
31.10Consolidated Financial Statements for the six-month period ended September 30, 2024
31.10Notice regarding the revision of the business results forecasts
Industrial Goods and Services »
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 6
05.11Tropical Storm Rafael Wind Speed Probabilities Number 6
05.11Tropical Storm Rafael Public Advisory Number 6
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 6
05.11Why colouring clothes has a big environmental impact
05.11Atlantic Tropical Weather Outlook
More »